Loyola Medicine, also known as Loyola University Health System, is a quaternary-care system with a 61-acre main medical center campus in the western suburbs of Chicago, in the U.S. state of Illinois. The medical center campus is located in Maywood, 13 miles west of the Chicago Loop and 8 miles east of Oak Brook.

There are 547 beds in Loyola University Medical Center.

During the past decade, Loyola University Medical Center conducted 378 clinical trials. In the 10-year time frame, 378 clinical trials started and 292 clinical trials were completed, i.e. on average, 77.2% percent of trials that started reached the finish line to date. In the past 5 years, 148 clinical trials started and 155 clinical trials were completed. i.e. 104.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Loyola University Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 167 trials, followed by "SWOG Cancer Research Network" with 89 trials sponsored, "Loyola University" with 79 trials sponsored, "Children's Oncology Group" with 52 trials sponsored and "Radiation Therapy Oncology Group" with 52 trials sponsored. Other sponsors include 406 different institutions and companies that sponsored additional 211 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loyola University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 294 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "SWOG Cancer Research Network" with 22 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 20 trials as a collaborator and "Eastern Cooperative Oncology Group" with 16 trials as a collaborator. Other collaborators include 404 different institutions and companies that were collaborators in the rest 233 trials.

According to Clinical.Site data, the most researched conditions in "Loyola University Medical Center" are "Breast Cancer" (23 trials), "Prostate Cancer" (18 trials), "Lung Cancer" (17 trials), "Multiple Myeloma" (16 trials) and "Head and Neck Cancer" (15 trials). Many other conditions were trialed in "Loyola University Medical Center" in a lesser frequency.

Most popular intervention types in "Loyola University Medical Center" are "Drug" (599 trials), "Other" (272 trials), "Biological" (192 trials), "Procedure" (158 trials) and "Radiation" (155 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (125 trials), "Quality-of-Life Assessment" (71 trials), "Placebo" (70 trials), "Cyclophosphamide" (57 trials) and "Questionnaire Administration" (45 trials). Other intervention names were less common.

The vast majority of trials in "Loyola University Medical Center" are 695 trials for "All" genders, 113 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are NaN active trials in "Loyola University Medical Center". undefined are not yet recruiting, 122 are recruiting, 185 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 394 completed trials in Loyola University Medical Center, 11 suspended trials, and 82 terminated clinical trials to date.

Out of the total trials that were conducted in Loyola University Medical Center, 53 "Phase 1" clinical trials were conducted, 321 "Phase 2" clinical trials and 337 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 40 trials, and there were also 98 trials that are defined as “Not Applicable".